These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, Morschhäuser J. Antimicrob Agents Chemother; 1998 Dec; 42(12):3065-72. PubMed ID: 9835492 [Abstract] [Full Text] [Related]
6. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV+ patients with candidiasis. Shokri H, Sharifzadeh A. J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362 [Abstract] [Full Text] [Related]
7. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW. Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667 [Abstract] [Full Text] [Related]
13. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China. Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R. J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443 [Abstract] [Full Text] [Related]
14. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model. Reynes J, Mallie M, Ravisse P, Bastide JM. J Med Vet Mycol; 1992 Oct; 30(5):363-7. PubMed ID: 1469537 [Abstract] [Full Text] [Related]
15. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors. Lacassin F, Damond F, Chochillon C, Longuet P, Lebras J, Vilde JL, Leport C. Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316 [Abstract] [Full Text] [Related]
16. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. Vuffray A, Durussel C, Boerlin P, Boerlin-Petzold F, Bille J, Glauser MP, Chave JP. AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555 [No Abstract] [Full Text] [Related]
17. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. Metzger S, Hofmann H. Mycoses; 1997 May; 40 Suppl 1():56-63. PubMed ID: 9417515 [Abstract] [Full Text] [Related]
18. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Tapia C, González P, Pereira A, Pérez J, Noriega LM, Palavecino E. Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812 [Abstract] [Full Text] [Related]
19. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients. Chryssanthou E, Torssander J, Petrini B. Scand J Infect Dis; 1995 May; 27(4):391-5. PubMed ID: 8658076 [Abstract] [Full Text] [Related]
20. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients. Kelly SL, Lamb DC, Kelly DE, Loeffler J, Einsele H. Lancet; 1996 Nov 30; 348(9040):1523-4. PubMed ID: 8942815 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]